// App-Quantinova.ai

4398 : Impact of Interleukin-22 on K-ras mutant lung tumor microenvironment and stemness properties

Researchers

Presenter

  • Nasim Khosravi

Principal Investigators

  • Amber M. Cumpian

  • Soudabeh Daliri

  • Cynthia De La Garza

  • Mauricio S. Caetano

  • Seyed Javad Moghaddam

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Colorectal Cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • NANOG

  • Cluster of Differentiation 4

  • Forkhead Box P3

  • Interleukin 17A

  • Interleukin 6

  • Interleukin-22

  • KRAS proto-oncogene, GTPase

  • Signal transducer and activator of transcription 3

  • SRY-Box 2

  • Tumor necrosis factor

  • Type 1 T helper

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved